Loading...
  • olanzapine
  • Despite of the high number of prescribing olanzapine, however, cost-effectiveness of olanzapine versus risperidone is still debated. (uio.no)
  • Results: The total five-year expected cost per schizophrenic patient for olanzapine was NOK 1,878,072 and for risperidone NOK 1,943,868. (uio.no)
  • The total expected PANSS reductions were 112.60 and 111.55 for olanzapine and risperidone, respectively, thus olanzapine was a dominant alternative to risperidone. (uio.no)
  • However, the results from the PSA using Monte Carlo simulation indicated that olanzapine and risperidone are not different in terms of cost-effectiveness within 95% confidence interval. (uio.no)
  • Discussion and conclusion: Considering all of the uncertainties surrounding the costs and effectiveness of the olanzapine and risperidone, the model could not conclude that olanzapine was more cost-effective than risperidone in Norway. (uio.no)
  • There were patients (n = 16) who received risperidone, who received quetiapine (n = 20), and who received olanzapine (n = 15), as an adjunctive treatment to either citalopram or venlafaxine for at least 8 weeks. (dovepress.com)
  • Quetiapine, risperidone, and olanzapine, given as adjunctive treatment with SSRIS or SNRIs can significantly and equally improve depressive and psychotic symptoms, in the short-term treatment of major depression with psychotic features. (dovepress.com)
  • Agents with relatively weak dopamine inhibiting effects (e.g. clozapine and quetiapine), for example, would theoretically have a cognitive profile superior to that of agents with higher degrees of dopaminergic inhibition (all traditional agents, risperidone, olanzapine and ziprasidone) when used for conditions associated with diminished dopamine function (e.g. idiopathic Parkinson's disease). (biopsychiatry.com)
  • Drugs with weak anticholinergic effects (high-potency traditional agents, risperidone, quetiapine and ziprasidone) would theoretically be less likely to cause cognitive impairment than agents with high degrees of cholinergic receptor blocking actions (clozapine and olanzapine) when treating patients with impaired cholinergic function (e.g. (biopsychiatry.com)
  • 2016
  • Pharmacogenetics of risperidone and cardiovascular risk in children and adolescents," International Journal of Endocrinology , vol. 2016, Article ID 5872423, 10 pages, 2016. (hindawi.com)
  • drug
  • Consequently, the clinical effect of the drug likely results from the combined concentrations of risperidone and 9-OH-risperidone. (labcorp.com)
  • Castberg I, Spigset O. Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone evidence from a routine therapeutic drug monitoring service. (labcorp.com)
  • Risperidone (Risperdal®) is an antipsychotic drug used in the treatment of disorganized or psychotic thinking. (psyweb.com)
  • Risperidone should not be used by elderly people suffering from dementia since the drug may cause pneumonia or heart failure to develop in older individuals. (livestrong.com)
  • To ensure adequate therapeutic plasma concentrations are maintained prior to the main release phase of drug from the injection, oral risperidone (or another antipsychotic drug) should be given for 3 weeks following the first injection. (drugs.com)
  • Risperidone is also used for the short-term treatment of behavioural problems (such as verbal or physical aggression, suspiciousness, and agitation) in people with severe dementia of the Alzheimer type that has not responded to non-drug approaches and when there is a risk of harm to self or others. (medbroadcast.com)
  • In contrast to lorazepam, risperidone treatment did not result in building of tolerance to the drug or disinhibition. (clinicaltrials.gov)
  • Risperidone is a newer antipsychotic drug that was the first available as a long-lasting injection (a depot injection). (cochrane.org)
  • Risperidone is the first new generation antipsychotic drug made available in a long-acting injection formulation. (cochrane.org)
  • De Leon J, Susce MT, Pan RM, Fairchild M, Koch WH, Wedlund PJ (2005) The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation. (springer.com)
  • Eap CB, Bondolfi G, Zullino D, Bryois C, Fuciec M, Savary L, Jonzier-Perey M, Baumann P (2001) Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test. (springer.com)
  • Over 2100 induction time experiments were carried out for the medium-sized, antipsychotic drug molecule, risperidone in seven different organic solvents. (rsc.org)
  • injections
  • Tell your doctor if you are pregnant or plan to become pregnant while receiving risperidone injections or within 12 weeks after you stop using this medicine. (cigna.com)
  • Tell your doctor if you become pregnant while receiving risperidone injections. (cigna.com)
  • side
  • Risperidone can pass into breast milk and may cause side effects in the baby. (drugs.com)
  • Risperidone use may cause several side effects, including significant weight gain. (livestrong.com)
  • Using risperiDONE together with gabapentin may increase side effects such as dizziness, drowsiness, confusion, and difficulty concentrating. (drugs.com)
  • Each white, film-coated, caplet-shaped, biconvex tablet marked with '1' on one side and scored notch on the other contains 1 mg of risperidone. (medbroadcast.com)